Skip to main content
Published Online:pp 363-380https://doi.org/10.1504/IJHTM.2002.001149

In this manuscript, we bridge two important, but often separate, streams of strategy research on the core competence perspective and upper echelons theory. We develop a model of how top management team characteristics influence the choices made concerning resources and capabilities pursued by pharmaceutical firms and how those choices impact innovative productivity. In particular, we propose how top management team tenure, education level and functional background, as well as heterogeneity in top management team tenure and functional background, influence product line breadth and the frequency of new product market entry, in-house R&D efforts and strategic alliances.

Keywords

corporate research, innovation, top management teams, pharmaceutical industry, resources, capabilities